Latest News & Features
Americas
Judges at Munich Local Division determined that Meril infringed Edwards Lifesciences’ patent | Meril ordered to stop selling and recall product as well as pay damages. 19 November 2024
Americas
US Supreme Court blocks bid to overturn lower court ruling | District court found in 2023 that the generic would infringe patents owned by a Bausch subsidiary | Blockbuster drug Xifaxan is used to treat IBS with diarrhoea, and a liver-related brain disorder. 19 November 2024
Americas
Vidal to return to Silicon Valley litigation department and advise on AI issues | Firm is ‘thrilled to welcome Kathi back’ and looking forward to benefitting from her leadership expertise. 19 November 2024
Americas
Patents are key to ensuring continued investment in pharma R&D.
What are the unique patent considerations for pharma/biotech patents and AI patents in Europe? 14 November 2024
Europe
European patent related to an inhaler revoked following successful appeal by GSK | Ruling comes after a series of challenges over novelty and inventive step | Decision further intensifies ongoing patent disputes between the pharma giants. 14 November 2024
Americas
Michael Summersgill and his co-counsel at WilmerHale secured more favourable outcomes for their clients than others in a series of lawsuits brought by Ravgen over pre-natal screening tests, he tells Sarah Speight. 14 November 2024
Americas
Board elected new president and officers at this year’s Leadership Meeting in New Orleans | Details released on updates to trademark law guidelines and new Think Tank. 14 November 2024
Americas
Vidal announced she will return to private sector after December departure | USPTO director told colleagues they had “transformed” the agency during her time there. 14 November 2024
Europe
Transatlantic deal would make ‘HSF Kramer’ a top 20 global firm by revenue | ‘Transformational’ combination a ‘one-of-a-kind’ opportunity, say firms’ leaders | HSF Kramer would have 2,700 lawyers, including 640 partners across 25 offices | IP practice would have approximately 32 partners. 14 November 2024
Americas
Oral arguments heard in case between Teva and generics maker Amneal over inhaler patents | Teva says district court and Amneal asked court to ‘slice apart new drug application’. 12 November 2024